Pharmacokinetics of dopamine in critically ill newborn infants

J Pediatr. 1990 Sep;117(3):472-6. doi: 10.1016/s0022-3476(05)81101-1.

Abstract

Dopamine pharmacokinetics was investigated in 14 critically ill newborn infants ranging from 27 to 43 weeks of gestational age and from 0.9 to greater than 4 kg birth weight. Plasma clearance rate was determined from dopamine levels during controlled infusions under actual clinical conditions. Dopamine was administered in stepwise increasing doses up to 8 micrograms/kg/min. Dopamine concentration and dopamine clearance rate were determined from duplicate samples drawn during each infusion in each patient. Steady-state plasma dopamine concentrations and plasma clearance rates were observed within 20 minutes at each infusion. Plasma dopamine concentration ranged from 0.5 ng/ml before infusion to almost 70 ng/ml at an infusion rate of 4 to 8 micrograms/kg/min. There was a linear correlation between infusion rate and plasma dopamine concentration (r = 0.68, p less than 0.001). Neither plasma dopamine concentration nor infusion rate had a significant effect on clearance rate. These data are consistent with first-order kinetics for administered dopamine in critically ill neonates over the range of concentrations studied.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Birth Weight
  • Critical Care
  • Dopamine / administration & dosage
  • Dopamine / blood
  • Dopamine / pharmacokinetics*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / metabolism*
  • Infusions, Intravenous
  • Metabolic Clearance Rate

Substances

  • Dopamine